Novartis India gets FIPB nod to sell OTC biz to GSK CPL

Last Updated: Friday, August 28, 2015, 19:32

The Foreign Investment Promotion Board (FIPB) has approved the proposal made by GSK CPL to acquire the company's OTC division, Novartis India said in a BSE filing.

Novartis India arm says unaware of any delisting plan

Last Updated: Thursday, June 11, 2015, 19:51

"The board of the company has not received any notice from the promoters of the company, Novartis AG, on its intention to delist the equity shares of the company from the Bombay Stock Exchange Limited," Novartis India said in a statement after trading hours.

High Court stays Rs 1.35 cr demand slapped on Novartis by NPPA

Last Updated: Monday, June 1, 2015, 17:15

Novartis, in its plea, claimed that the government by a June 14, 2013 notification had revised the price of its drug, Regestrone, used for regulating women's menstrual cycle.

Novartis India Q4 net up 2 folds at Rs 51.94 cr

Last Updated: Wednesday, May 27, 2015, 18:15

Pharmaceuticals firm Novartis India Wednesday reported over two-fold increase in standalone net at Rs 51.94 crore for the fourth quarter ended March 31, 2015.

Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr

Last Updated: Tuesday, January 13, 2015, 19:15

Novartis India's board on Tuesday approved the sale of its OTC division to GlaxoSmithKline Consumer Pvt Ltd, a consumer healthcare joint venture between Novartis AG and GSK, for a consideration of Rs 109.7 crore.

Novartis shares up nearly 2% at close

Last Updated: Wednesday, December 24, 2014, 13:59

Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 percent higher Wednesday, a day after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis.

Novartis India Q2 Net up 16% at Rs 45.55 cr

Last Updated: Wednesday, October 30, 2013, 19:13

Drug firm Novartis India on Wednesday reported 15.78 percent rise in net profit to Rs 45.55 crore for the quarter ended September 30, on the back of a favourable ruling in a dispute that resulted in higher tax credit.

Govt refutes Novartis' allegations on patents

Last Updated: Wednesday, August 28, 2013, 19:24

"You would appreciate that more than 80 percent of patents registered in India are attributed to non-Indians," Commerce Secretary S R Rao has said in a letter to Novartis AG CEO Joseph Jimenez.

Novartis Q1 Net down 49% at Rs 14 crore

Last Updated: Wednesday, July 24, 2013, 20:12

Drug major Novartis India Wednesday said its net profit declined by 48.69 percent to Rs 13.8 crore for the first quarter ended June 30, 2013, on account of rupee depreciation and slowdown in sales due to notification of new drug policy.

Novartis AG sells 1.42 stake in Indian arm for Rs 25 cr

Last Updated: Friday, June 28, 2013, 19:35

Drug firm Novartis India Friday said its parent Novartis AG has offloaded 1.42 percent stake in it through open market for a consideration of over Rs 25 crore to meet market regulator SEBI guidelines.

Novartis India Q4 net profit dips 26% at Rs 24 cr

Last Updated: Tuesday, May 14, 2013, 18:47

The company had posted a net profit of Rs 32.91 crore for the quarter ended March 31, 2012.

Novartis appoints Citigroup as broker for Indian co share sale

Last Updated: Thursday, May 9, 2013, 15:09

Drug major Novartis India Thursday said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share sale to reduce stake in the Indian entity.